Brain-Derived Neurotrophic Factor in Obesity and Brain Function
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01517048 |
Recruitment Status :
Completed
First Posted : January 25, 2012
Last Update Posted : December 17, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Background:
- Prader-Willi syndrome (PWS) and MC4R genetic mutations are two conditions that can cause problems with appetite regulation. People with PWS often have behavior and thinking problems. People with MC4R mutations may have problems with attention. These problems may be related to Brain-Derived Neurotrophic Factor (BDNF), a protein that is important for brain development. Researchers want to study people with PWS and MC4R mutations to see how BDNF is involved in these conditions. Specifically, body weight and brain function will be studied, and compared with healthy volunteers.
Objectives:
- To study how BDNF affects body weight and brain function in people with PWS and MC4R mutations.
Eligibility:
- Individuals of any age who have Prader-Willi syndrome or MC4R genetic mutations.
- Healthy volunteers of any age to act as control participants.
Design:
- Participants will be screened with a medical history and physical exam. Height, weight, and waist/hip circumferences will be measured. Blood samples will be taken for genetic and other tests.
- Participants will fill out questionnaires about eating habits, pain perception, and sleep behavior.
- Participants will keep a 3-day food diary to record all food and drinks eaten.
- Tests and questionnaires will be given to study thinking, speech, movement, behavior, and mood. Some tests will be done on a computer; other tests will be on paper. Tests may also involve performing tasks with blocks and other objects.
- Participants may have other tests as directed. These will include hot and cold sensitivity tests, imaging studies like x-rays, and measurements of body fat and water content.
- Treatment will not be provided as part of this study.
Condition or disease |
---|
Obesity Genetic Disorder Mental Retardation Developmental Delay |
Study Type : | Observational |
Actual Enrollment : | 93 participants |
Observational Model: | Case-Control |
Time Perspective: | Cross-Sectional |
Official Title: | Brain-Derived Neurotrophic Factor in Obesity and Neurocognitive Function |
Study Start Date : | January 9, 2012 |
Study Completion Date : | December 12, 2014 |

- Serum brain-derived neurotrophic factor concentration
- Body Composition, Cognitive Function

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 99 Years (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
- INCLUSION CRITERIA:
Subject Inclusion Criteria:
- For PWS subjects: We will enroll 75 subjects of all ages who have diagnosis of PWS confirmed by chromosome analysis (i.e. interstitial deletion of paternally-derived chromosome 15q, uniparental maternal disomy or other chromosome 15 abnormalities). Our goal is to have 25 infants, 25 non-obese, and 25 obese subjects in order to assess the different phases associated with PWS. Subjects receiving growth hormone therapy may enroll if the dose has been stable for the preceding 6 months.
- For MC4R subjects: We will screen up to 200 subjects for mutations of MC4R and enroll 50 subjects of all ages who have diagnosis of homozygous or heterozygous MC4R mutation confirmed by sequencing of the MC4R gene. Both functional-altering (N=25) and non-pathologic (N=25) mutations will be included.
- For control subjects: We will enroll 125 subjects of all ages who match with PWS or MC4R subjects by age (plus-minus 10%), sex, race, and BMI percentile (plus-minus10%).
EXCLUSION CRITERIA:
Subject Exclusion Criteria:
-
For all subjects:
- Pregnancy
- Individuals who have, or whose parent or guardians have, current substance abuse or a psychiatric disorder or other condition which, in the opinion of the investigators, would impede competence or compliance or possibly hinder completion of the study
- If age >12 months, greater than 2% body weight loss in preceding 6 months
- Anorexiant or weight loss medication use in preceding 6 months
-
For control subjects:
- Chronic medical conditions anticipated to affect results or impede study participation
- Medication use will be reviewed on a case-by-case basis by the Principal Investigator to determine eligibility

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01517048
United States, Maryland | |
National Institutes of Health Clinical Center, 9000 Rockville Pike | |
Bethesda, Maryland, United States, 20892 | |
Canada | |
University of Alberta | |
Alberta, Canada |
Principal Investigator: | Jack A Yanovski, M.D. | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
ClinicalTrials.gov Identifier: | NCT01517048 |
Other Study ID Numbers: |
120051 12-CH-0051 |
First Posted: | January 25, 2012 Key Record Dates |
Last Update Posted: | December 17, 2019 |
Last Verified: | December 12, 2014 |
Body Composition Obesity Overweight Energy Homeostasis Nociception |
Prader-Willi Syndrome Genetic Disorder Healthy Volunteer HV |
Intellectual Disability Genetic Diseases, Inborn Obesity Overnutrition Nutrition Disorders Overweight |
Body Weight Neurobehavioral Manifestations Neurologic Manifestations Nervous System Diseases Neurodevelopmental Disorders Mental Disorders |